Clinical trial
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
NCT00074581 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00074581 |
|---|---|
| Title | Preventing Sexual Transmission of HIV With Anti-HIV Drugs |
| Official title | A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care Versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | HIV Prevention Trials Network |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atazanavir, Didanosine, Efavirenz, Emtricitabine/Tenofovir disoproxil fumarate, Lamivudine, Lopinavir/Ritonavir, Nevirapine, Stavudine, Tenofovir disoproxil fumarate, Zidovudine/Lamivudine |
| Enrollment | 3,526 |
| Start date | Feb 1, 2005 |
| Primary completion | May 1, 2015 |
| Completion | May 1, 2015 |
| First posted | Dec 17, 2003 |
| Last update posted | Nov 5, 2021 |
| Countries | Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, United States, Zimbabwe |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: